Bracco Imaging's VueJect Contrast Delivery System Receives US and Canadian Regulatory Approvals

Bracco Imaging has secured 510(k) clearance from the U.S. Food and Drug Administration and authorization from Health Canada for its VueJect contrast delivery system. This device is designed to administer ultrasound contrast agents for cardiology imaging procedures. The approvals enable distribution in both countries, aiming to enhance consistency and confidence in contrast administration during clinical practice.